Wednesday, June 10, 2026

pharma

Axxonis Pharma AG

Axxonis Pharma AG patent portfolio β€” 8 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

EU HQ
EMA registrant Type
Company details
Status
Public
HQ
EU
Programs
0
Drugs
0
Patents
8
Intelligence Β· Patents

Axxonis Pharma AG patents

8 pharmaceutical patents indexed for Axxonis Pharma AG. 2 expire within 24 months.

Axxonis Pharma AG has 8 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months β€” use filters for patent-cliff planning.

Patent portfolio

  1. CA 2626142

    SOLUTIONS AQUEUSES STABILISEES DE COMPOSES D'ERGOLINE

    Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. DE 102006048130

    Transdermales therapeutisches System mit zweiphasigem Freisetzungsprofil

    Expires Wed Apr 05 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. IT MI20070164

    CEROTTO TRANSDERMICO

    Expires Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. DE 102004006048

    Pharmazeutische Kombination aus Gadolinium Komplexen und kolloidalen Biopolymeren und deren Verwendung als kontrastverstΓ€rkendes Mittel zur i.v. Injektion bzw. i.v. Infusion in der MR Angiographie

    Expires Wed Aug 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  5. DE 10341317

    Mittel zur transdermalen Applikation

    Expires Wed Mar 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  6. AU 2002363847

    1-ALLYL ERGOT ALKALOID DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THE USE THEREOF FOR PREVENTING AND TREATING MIGRAINE

    Expires Sun Sep 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  7. EP 1311248

    TRANSDERMALES THERAPEUTISCHES SYSTEM ZUR BEHANDLUNG DES RESTLESS-LEGS-SYNDROMS

    Expires Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  8. EP 1303278

    KOMBINATION EINES TRANSDERMALEN THERAPEUTISCHEN SYSTEMS UND EINER ORALEN UND/ODER PARENTERALEN ZUBEREITUNG ENTHALTEND DOPAMINAGONISTEN ZUR BEHANDLUNG DOPAMINERGER ERKRANKUNGEN

    Expires Tue Apr 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Axxonis Pharma AG have?

8 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Axxonis Pharma AG patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.